Written question WQ97452

Asked by: Sam RowlandsConservativeMember for North Wales
To be answered by: Cabinet Secretary for Health and Social Care
Tabled: 23 September 2025
Due: 29 September 2025
Answered: Awaiting answer

Question

What plans does the Cabinet Secretary have to ensure equitable access to calcitonin gene-related peptide monoclonal antibodies and calcitonin gene-related peptide receptor antagonists for migraine treatment across Wales?

Answer

The due date has passed and no answer has been published yet.

Open Senedd last checked for an answer on 26 October 2026.